Lexicon Pharma (LXRX) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.24 --0%
EPS Growth %: -50.0%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
FIZZ, LAKE, BNED, More
EPS Growth %: -50.0%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
FIZZ, LAKE, BNED, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.37), $0.04 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $20.1 million versus the consensus estimate of $12.36 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Roth/MKM Downgrades eGain Corporation (EGAN) to Neutral
- UBS Upgrades Feng Tay Enterprises (9910:TT) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
